Synergy CHC (SNYR) AI Stock Analysis

• Market Cap: $30.65M
• Dividend Yield: N/A
• Average Volume (3M): 93.14K
• Price to Earnings (P/E): 3.1
• Beta (1Y): 0.74
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 21
• Sector: Consumer Defensive
• Sector Strength: 56
• Industry: Medical - Distribution
• EPS (TTM): 0.10
• Shares Outstanding: 9,014,110
• 10 Day Avg. Volume: 60,633
• 30 Day Avg. Volume: 93,142
• PEG Ratio: -0.19
• Price to Book (P/B): -2.75
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -3.89
• Enterprise Value/Market Cap: 1.63
• Enterprise Value/Revenue: 0.56
• Enterprise Value/Gross Profit: 2.86
• Enterprise Value/Ebitda: 2.93
• 1Y Price Target: $10.00
• Price Target Upside: 191.55% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 47 Neutral
• Price Target: ―

Synergy CHC presents a mixed outlook. While the stock is undervalued based on its P/E ratio, significant financial risks due to high leverage and liquidity issues are concerning. The company's bearish technical indicators and lack of a clear positive earnings call narrative further weigh down the score. On the positive side, corporate events such as leadership changes and strategic partnerships suggest potential future growth.

Synergy CHC Business Overview & Revenue Model

Company Description

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.

How the Company Makes Money

Synergy CHC generates revenue primarily through the sale of its health and wellness products. The company markets and distributes these products through various retail channels, including online platforms and brick-and-mortar stores. Key revenue streams include direct sales to consumers and partnerships with retailers who stock and sell Synergy CHC's product lines. The company's earnings are significantly influenced by their marketing strategies, product innovation, and ability to establish strong brand recognition in the competitive consumer health care market.

Synergy CHC Financial Statement Overview

Summary

Synergy CHC shows revenue growth, but profitability is inconsistent, with significant financial instability due to high leverage and negative equity. Cash flow struggles further highlight liquidity issues, despite some operational efficiencies.

Income Statement

Synergy CHC shows a mixed income statement performance with a significant increase in total revenue from 2023 to 2024. However, the net profit margin remains low and inconsistent over the years, highlighting challenges in achieving sustained profitability. The EBIT and EBITDA margins are positive, indicating some operational efficiencies, yet net income remains volatile.

Balance Sheet

The company's balance sheet indicates high leverage with a significant debt-to-equity ratio due to negative equity, which poses financial risks. ROE is not meaningful due to negative equity, and the equity ratio is also negative. These factors suggest financial instability and potential challenges in meeting long-term obligations.

Cash Flow

Cash flow analysis reveals negative operating and free cash flows in recent years, reflecting liquidity struggles. The operating cash flow to net income ratio is concerning, indicating difficulty in translating profits into cash. Despite these challenges, financing activities have been positive, suggesting reliance on external funding.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	25.57M	34.83M	42.78M	38.41M	0.00	40.23M
Gross Profit	17.46M	23.64M	32.08M	13.30M	0.00	25.55M
EBITDA	5.02M	6.47M	10.84M	-24.63M	0.00	3.19M
Net Income	1.77M	2.12M	6.34M	-32.63M	0.00	1.41M
Balance Sheet
Total Assets	15.66M	16.34M	12.24M	18.54M	0.00	12.59M
Cash, Cash Equivalents and Short-Term Investments	177.88K	687.92K	632.53K	1.93M	0.00	1.67M
Total Debt	28.12M	27.52M	27.63M	22.83M	0.00	8.75M
Total Liabilities	23.23M	32.97M	39.55M	52.06M	0.00	16.27M
Stockholders Equity	-7.57M	-16.63M	-27.31M	-33.52M	0.00	-3.68M
Cash Flow
Free Cash Flow	-4.77M	-4.80M	421.73K	-8.43M	0.00	-1.59M
Operating Cash Flow	-4.77M	-4.80M	421.73K	-8.43M	0.00	-1.59M
Investing Cash Flow	0.00	0.00	0.00	0.00	0.00	―
Financing Cash Flow	4.11M	4.80M	-2.09M	8.96M	0.00	1.95M

Synergy CHC Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3.43
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNYR, the sentiment is Positive. The current price of 3.43 is above the 20-day moving average (MA) of 2.99, above the 50-day MA of 2.40, and below the 200-day MA of 3.76, indicating a neutral trend. The MACD of 0.32 indicates Negative momentum. The RSI at 71.76 is Negative, neither overbought nor oversold. The STOCH value of 94.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SNYR.

Synergy CHC Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PBH	69 Neutral	$3.70B	17.54	12.30%	―	1.10%	2.65%
Sector *	65 Neutral	$26.91B	15.42	-4.18%	3.21%	1.01%	1.34%
OMI	50 Neutral	$607.55M	―	-49.91%	―	2.84%	-828.91%
SNYR	47 Neutral	$30.65M	3.07	-23.21%	―	―	―
GRDN	47 Neutral	$1.33B	―		―	―	―
RDGT	40 Underperform	$7.41M	―	-27.69%	―	-4.87%	94.14%
ZYXI	39 Underperform	$68.64M	24.14	-27.52%	―	-8.63%	-202.31%

Synergy CHC Corporate Events

Synergy CHC Appoints New CFO Amidst Leadership Changes

On March 27, 2025, Synergy CHC appointed Jaime Fickett as the new Chief Financial Officer, marking a significant leadership change. The company reported its eighth consecutive quarter of profitability for 2024, despite a decrease in revenue and net income due to rebranding efforts and retailer de-inventorying. Synergy successfully completed its initial public offering in October 2024 and expanded its partnerships with major retailers, positioning itself for future growth.